Twin Focus Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Twin Focus Capital Partners's AMGN Position: Q3 2023 in Review
Twin Focus Capital Partners sold out of Amgen (AMGN) in Q3 2023, closing a stake of 1,547 shares — an estimated $343K sold.
Twin Focus Capital Partners first reported a position in AMGN in Q2 2019 and held it in 14 quarters. The position peaked at $406K in Q4 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.
- Twin Focus Capital Partners reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
- Twin Focus Capital Partners sold 1,547 Amgen shares in Q3 2023, an estimated $343K.
- Twin Focus Capital Partners first reported a position in Amgen in Q2 2019 and held it in 14 quarters.
- Twin Focus Capital Partners's Amgen position peaked at $406K in Q4 2022.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.
Based on Twin Focus Capital Partners's 13F filing for Q3 2023, filed 13 Nov 2023.